| Source HCPCS Code |
|
Target NDC Code |
Q0180
DOLASETRON MESYLATE, 100 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 24 HOUR DOSAGE REGIMEN
|
⇄
|
00088-1202-05
ANZEMET 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2002 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0180
DOLASETRON MESYLATE, 100 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 24 HOUR DOSAGE REGIMEN
|
⇄
|
00088-1202-29
ANZEMET (BLISTER PACK,1X5) 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
8/4/2004 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0180
DOLASETRON MESYLATE, 100 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 24 HOUR DOSAGE REGIMEN
|
⇄
|
00088-1202-43
ANZEMET 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
8/8/2011 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0180
DOLASETRON MESYLATE, 100 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 24 HOUR DOSAGE REGIMEN
|
⇄
|
00088-1203-05
ANZEMET 100 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2002 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0180
DOLASETRON MESYLATE, 100 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 24 HOUR DOSAGE REGIMEN
|
⇄
|
00088-1203-29
ANZEMET (BLISTER PACK,1X5) 100 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
10/15/2004 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0180
DOLASETRON MESYLATE, 100 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 24 HOUR DOSAGE REGIMEN
|
⇄
|
00088-1203-43
ANZEMET 100 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
8/8/2011 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0180
DOLASETRON MESYLATE, 100 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 24 HOUR DOSAGE REGIMEN
|
⇄
|
54569-4870-00
ANZEMET 100 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
1/31/2003 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0180
DOLASETRON MESYLATE, 100 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 24 HOUR DOSAGE REGIMEN
|
⇄
|
54868-4138-00
ANZEMET 100 MG
|
| Detail Information |
| Relationship Start Date |
2/10/2005 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0180
DOLASETRON MESYLATE, 100 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 24 HOUR DOSAGE REGIMEN
|
⇄
|
54868-4138-01
ANZEMET 100 MG
|
| Detail Information |
| Relationship Start Date |
9/22/2005 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|